SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,958.00    80.00 (2.78%)
Bid:
2,950.00
Ask:
2,956.00
Spread: 6.00 (0.203%)
Market Cap: £1.63b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Half Year Trading Update

16 Oct 2024 07:00

RNS Number : 3121I
Oxford Instruments PLC
16 October 2024
 

 

Oxford Instruments plc

Half-year trading update - 16 October 2024

 

 

Robust demand and order intake growthFull year trading in line with constant currency expectations

 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2024.

 

At constant currency, we expect to deliver circa 10% revenue growth for the first half, supported by order intake circa 3% ahead of the prior year. Adjusted operating profit will be slightly above last year. Group margin will be lower than last year, as expected, reflecting the mix effect of stronger revenue growth from Advanced Technologies.

 

On a reported basis, the currency headwind will result in adjusted operating profit and margin below the comparable period last year.

 

Imaging & Analysis

We have continued to see good growth in the first half of this financial year, with strong demand across our materials analysis and semiconductor markets. This more than offset softer demand from our healthcare & life science market. The division recorded a positive book-to-bill in the half year.

 

Advanced Technologies

Our compound semiconductor business continues to perform well, with strong revenue growth in the first half. In the quantum market, we have begun deliveries of an ongoing series of orders to a key customer, supporting good progress towards a return to profitability. The division continues to have good order book visibility.

 

Outlook

We expect to deliver our normal stronger second half trading performance. This will be supported by the execution of some larger orders in Advanced Technologies, as well as progress in our operational transformation and business restructuring projects, delivering efficiency and cost improvements in the second half of the year. We expect performance for the full year to be in line with expectations on a constant currency basis.

 

Based on prevailing exchange rates, the appreciation of sterling is expected to increase the currency headwind on operating profit for the full year by circa £1.5-2.0m from previous guidance.2

 

Oxford Instruments' results for the half year ending 30 September 2024 will be released on 12 November 2024.

 

 

Notes:

 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and the mark-to-market revaluation of financial derivatives.

2. Guidance in our 2024 preliminary full-year results announcement in June pointed to a headwind of £8.4m to revenue and £6.2m to profit for the full year.

 

 

Enquiries:

 

Oxford Instruments plc

Richard Tyson, Chief Executive Officer

Gavin Hill, Chief Financial Officer

Stephen Lamacraft, Head of Investor Relations

 

Tel: 01865 393200

investors@oxinst.com

 

MHP Group

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

 

Tel: 07710 117517

oxfordinstruments@mhpgroup.com

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow.

Oxford Instruments holds a unique position to anticipate global drivers and connect academic researchers with commercial applications engineers, acting as a catalyst that powers real world progress.

Founded in 1959 as the first technology business to be spun out fromOxfordUniversity, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG).

For more information, visit www.oxinst.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKPBQABDDPKD
Date   Source Headline
2nd Jan 201911:33 amPRNHolding(s) in Company
17th Dec 20181:22 pmPRNHolding(s) in Company
12th Dec 201810:25 amPRNDirector/PDMR Shareholding
11th Dec 20185:07 pmPRNHolding(s) in Company
10th Dec 20189:34 amPRNHolding(s) in Company
3rd Dec 20183:20 pmPRNHolding(s) in Company
28th Nov 20189:31 amPRNHolding(s) in Company
26th Nov 201810:17 amPRNAppointment of Chairman
22nd Nov 201810:26 amPRNHolding(s) in Company
13th Nov 20189:49 amPRNDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
11th Oct 201810:38 amPRNDirector/PDMR Shareholding
11th Sep 20184:07 pmPRNResult of AGM
11th Sep 20181:47 pmPRNDirector/PDMR Shareholding
11th Sep 20187:00 amRNSInterim Chairman's AGM Statement 2018
13th Aug 20183:27 pmPRNDirector/PDMR Shareholding
24th Jul 201812:00 pmPRNHolding(s) in Company
23rd Jul 20181:00 pmRNSDeath of Chairman
19th Jul 20187:00 amPRNHolding(s) in Company
11th Jul 201812:15 pmPRNHolding(s) in Company
11th Jul 201811:51 amPRNDirector/PDMR Shareholding
5th Jul 201811:09 amPRNBlocklisting - Interim Review
4th Jul 201812:02 pmPRNDirector/PDMR Shareholding
12th Jun 201810:46 amPRNDirector/PDMR Shareholding
12th Jun 20187:00 amRNSFinal Results
11th May 201812:07 pmPRNDirector/PDMR Shareholding
11th Apr 20187:00 amRNSTrading Update
9th Apr 201811:03 amPRNDirector/PDMR Shareholding
1st Mar 201812:35 pmPRNDirector/PDMR Shareholding
8th Feb 20189:36 amPRNDirector/PDMR Shareholding
1st Feb 201811:21 amPRNTotal Voting Rights
9th Jan 20189:59 amPRNBlocklisting - Interim Review
5th Dec 201710:43 amPRNTotal Voting Rights
16th Nov 20179:22 amPRNHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
31st Oct 201710:02 amPRNDirectorate Change
3rd Oct 201711:42 amPRNTotal Voting Rights
26th Sep 20172:02 pmPRNCorrection : Director/PDMR Shareholding
26th Sep 201710:57 amPRNDirector/PDMR Shareholding
12th Sep 201711:59 amPRNResult of AGM
12th Sep 20177:00 amRNSAGM Statement
4th Sep 201711:14 amPRNTotal Voting Rights
17th Aug 201710:26 amPRNHolding(s) in Company
8th Aug 201712:55 pmPRNTotal Voting Rights
4th Jul 201710:24 amPRNBlocklisting - Interim Review
4th Jul 201710:12 amPRNTotal Voting Rights
3rd Jul 20172:48 pmRNSCompletion of Sale of Industrial Analysis to HHT
13th Jun 20178:41 amRNSAppointment of Senior Independent Director
13th Jun 20177:03 amRNSAppointment of Senior Independent Director
13th Jun 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.